Catalyst
Slingshot members are tracking this event:
PharmaMar (PHM.MC) Expects Interim Analysis in Q2 from the Phase 3 INNOVATYON (IST) Study Evaluating Yondelis in Relapsed Ovarian Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PHM.MC |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2016
Occurred Source:
http://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.5046
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Interim Analysis, Ist, Relapsed Ovarian Cancer, Yondelis, Innovatyon, Phase 3
